1. Home
  2. Live Updates
  3. மருத்துவ நிகழ்வுகள் குழு

மருத்துவ நிகழ்வுகள் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருத்துவ நிகழ்வுகள் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருத்துவ நிகழ்வுகள் குழு Today - Breaking & Trending Today

Investegate |Sequana Medical NV Announcements | Sequana Medical NV: Sequana Medical announces positive results from second interim analysis of North American pivotal alfapump® study (POSEIDON)


Sequana Medical NV
(Euronext Brussels: SEQUA, the Company or Sequana Medical ), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces positive results from the second interim analysis of POSEIDON, the North American pivotal study of the
alfapump for the treatment of recurrent or refractory ascites due to liver cirrhosis. These interim data from 26 patients in the Roll-In Cohort are in line with the previous interim data
ii, including positive outcomes against all primary endpoints of the study and a rapid and persistent clinically important improvement in quality of life measures. ....

United States , Cian Crosbie , Florence Wong , Guillaume Van Renterghem , University Of Toronto , Company Or Sequana , Clinical Events Committee , Sequana Medical , North American , Roll In Cohortreconfirm , Euronext Brussels , Roll In Cohort , Pivotal Cohort , Premarket Approval , Chief Executive Officer , Toronto General Hospital , Principal Investigator , Minimal Clinically Important Difference , Clinical Events , Non Alcoholic Steatohepatitis , Direct Sodium Removal , ஒன்றுபட்டது மாநிலங்களில் , ஈயந் க்ராஸ்பி , புளோரன்ஸ் வோங் , பல்கலைக்கழகம் ஆஃப் டொராண்டோ , மருத்துவ நிகழ்வுகள் குழு ,

Diagnosis, Education, and Care of Patients with APOL1-Associated Nephropathy: A Delphi Consensus and Systematic Review

Diagnosis, Education, and Care of Patients with APOL1-Associated Nephropathy: A Delphi Consensus and Systematic Review
asnjournals.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asnjournals.org Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , United States , South Holland , Zuid Holland , Puerto Rico , Oak Ridge , Drexel University , Ovid Walters Kluwer , Brian Mcmunn Pharmagenesis , Sally Janani , Richard Claes , Sanofi Genzyme , Bristol Myers Squibbs , Texas Kidney Foundation , Bowie State University Board Of Advisors , Boehringer Ingelheim , Home Dialyzors United Advisory Committee , University Of Michigan , Forum Health Information Technology , Generation Kidney Research Meeting , Health Equity , Health Information Technology Workgroup , Community Advisory Committee , National Institutes Of Health , Patient Group ,

Sequana Medical NV: Sequana Medical announces positive results from second interim analysis of North American pivotal alfapump study (POSEIDON)


Sequana Medical NV: Sequana Medical announces positive results from second interim analysis of North American pivotal alfapump study (POSEIDON)
i
All patients experienced
Safety
Primary endpoint read-out
Sequana Medical NV
(Euronext Brussels: SEQUA, the Company or Sequana Medical ), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces positive results from the second interim analysis of POSEIDON, the North American pivotal study of the
alfapump for the treatment of recurrent or refractory ascites due to liver cirrhosis. These interim data from 26 patients in the Roll-In Cohort are in line with the previous interim data ....

United States , Cian Crosbie , Florence Wong , Guillaume Van Renterghem , University Of Toronto , Company Or Sequana , Clinical Events Committee , Roll In Cohortreconfirm , Euronext Brussels , North American , Roll In Cohort , Pivotal Cohort , Premarket Approval , Chief Executive Officer , Sequana Medical , Toronto General Hospital , Principal Investigator , Minimal Clinically Important Difference , Non Alcoholic Steatohepatitis , Direct Sodium Removal , ஒன்றுபட்டது மாநிலங்களில் , ஈயந் க்ராஸ்பி , புளோரன்ஸ் வோங் , பல்கலைக்கழகம் ஆஃப் டொராண்டோ , மருத்துவ நிகழ்வுகள் குழு , வடக்கு அமெரிக்கன் ,

BD Announces Enrollment in Post-Market Studies of the WavelinQ™ Arteriovenous Endovascular Fistula


Share this article
Share this article
FRANKLIN LAKES, N.J., April 29, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that enrollment has begun and the first patients have been treated in the post-market surveillance study, CONNECT-AV.
CONNECT-AV is a prospective, single-arm, open-label study that will follow patients treated with the WavelinQ
TM EndoAVF System for 24 months.
WavelinQ EndoAVF System
The study s dual primary effectiveness endpoints are the percentage of subjects dialyzing using successful 2-needle cannulation for at least 75% of the dialysis sessions over a continuous 28-day period at 6 months, and the subjects maintaining primary patency at 6 months. ....

United States , Butler Memorial Hospital , Panagiotism Kitrou , Brandon Repko , Troy Kirkpatrick , Kristenm Stewart , Clinical Affairs , National Institute Of Diabetes , National Institutes Of Health , Clinical Events Committee , Patras University Hospital , Nuclear Imaging , Medical Director , Therapeutic Services , Interventional Radiology , Patras University , Vice President , Global Studies , Public Relations , United States Renal Data , Data Report , National Institutes , National Institute , Kidney Diseases , Bd Becton , Dickinson And Company ,